Literature DB >> 10655107

Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro.

H Aoki1, J Sadoshima, S Izumo.   

Abstract

During the development of hypertrophy, cardiac myocytes increase organization of the sarcomere, a highly ordered contractile unit in striated muscle cells. Several hypertrophic agonists, such as angiotensin II, phenylephrine, and endothelin-1, have been shown to promote the sarcomere organization. However, the signaling pathway, which links extracellular stimuli to sarcomere organization, has not been clearly demonstrated. Here, we demonstrate that myosin light chain kinase specifically mediates agonist-induced sarcomere organization during early hypertrophic response. Acute administration of a hypertrophic agonist, phenylephrine, or angiotensin II, causes phosphorylation of myosin light chain 2v both in cultured cardiac myocytes and in the adult heart in vivo. We also show that both sarcomere organization and myosin light chain 2v phosphorylation are dependent on the activation of Ca2+/calmodulin pathway, a known activator of myosin light chain kinase. These results define a new and specific role of myosin light chain kinase in cardiac myocytes, which may provide a rapid adaptive mechanism in response to hypertrophic stimuli.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655107     DOI: 10.1038/72287

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  52 in total

1.  Automated image analysis identifies signaling pathways regulating distinct signatures of cardiac myocyte hypertrophy.

Authors:  Gregory T Bass; Karen A Ryall; Ashwin Katikapalli; Brooks E Taylor; Stephen T Dang; Scott T Acton; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2011-12-01       Impact factor: 5.000

2.  Differential effects of hypoxic and hyperoxic stress-induced hypertrophy in cultured chick fetal cardiac myocytes.

Authors:  Allison A Greco; George Gomez
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-29       Impact factor: 2.416

3.  Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing.

Authors:  Andrei B Borisov; Sarah B Sutter; Aikaterini Kontrogianni-Konstantopoulos; Robert J Bloch; Margaret V Westfall; Mark W Russell
Journal:  Histochem Cell Biol       Date:  2005-10-05       Impact factor: 4.304

4.  Subcellular localization, expression patterns, SNPs and association analyses of the porcine HUMMLC2B gene.

Authors:  Huan L Wang; Heng Wang; Zheng M Zhu; Chen F Wang; Meng J Zhu; De L Mo; Shu L Yang; Kui Li
Journal:  Mol Genet Genomics       Date:  2006-06-27       Impact factor: 3.291

Review 5.  Pseudophosphorylation of cardiac myosin regulatory light chain: a promising new tool for treatment of cardiomyopathy.

Authors:  Sunil Yadav; Danuta Szczesna-Cordary
Journal:  Biophys Rev       Date:  2017-01-25

6.  Significant role of female sex hormones in cardiac myofilament activation in angiotensin II-mediated hypertensive rats.

Authors:  Sulaksana Pandit; Warunya Woranush; Jonggonnee Wattanapermpool; Tepmanas Bupha-Intr
Journal:  J Physiol Sci       Date:  2014-04-29       Impact factor: 2.781

7.  Neuronal (pro)renin receptor regulates deoxycorticosterone-induced sodium intake.

Authors:  Fatima Trebak; Wencheng Li; Yumei Feng
Journal:  Physiol Genomics       Date:  2018-08-24       Impact factor: 3.107

8.  Identification of cardiac-specific myosin light chain kinase.

Authors:  Jason Y Chan; Morihiko Takeda; Laura E Briggs; Megan L Graham; Jonathan T Lu; Nobuo Horikoshi; Ellen O Weinberg; Hiroki Aoki; Naruki Sato; Kenneth R Chien; Hideko Kasahara
Journal:  Circ Res       Date:  2008-01-17       Impact factor: 17.367

9.  Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin/NFAT as Ca2+ signal integrators.

Authors:  Matilde Colella; Francesca Grisan; Valerie Robert; Jay D Turner; Andrew P Thomas; Tullio Pozzan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

10.  Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome.

Authors:  Xonia Carvajal-Vergara; Ana Sevilla; Sunita L D'Souza; Yen-Sin Ang; Christoph Schaniel; Dung-Fang Lee; Lei Yang; Aaron D Kaplan; Eric D Adler; Roye Rozov; Yongchao Ge; Ninette Cohen; Lisa J Edelmann; Betty Chang; Avinash Waghray; Jie Su; Sherly Pardo; Klaske D Lichtenbelt; Marco Tartaglia; Bruce D Gelb; Ihor R Lemischka
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.